This NEJM 2026 review shows that CAD polygenic risk scores (PRS) identify a high-risk group, often missed by traditional calculators and meaningfully improve risk prediction and provide absolute benefit is greatest in high-PRS individuals.
Learn more
This landmark JAMA 2025 trial showed that PRS-powered risk-based breast cancer screening was non-inferior to annual screening and was associated with an approximately one-third lower rate of advanced cancer.
This landmark JAMA 2025 WISDOM trial showed that PRS-powered risk-based breast cancer screening was non-inferior to annual screening and was associated with an approximately one-third lower rate of advanced (stage ≥IIB) cancers (30.0 vs 48.0 per 100,000 person-years), with nearly doubled uptake of preventive therapy among the highest-risk women, establishing PRS-guided screening as a scalable and clinically sound strategy.
Learn more
This landmark NEJM 2025 study showed that PRS-guided screening of men in the top genetic risk decile substantially improves detection of clinically significant prostate cancer, uncovering many high-risk cancers missed by standard PSA pathways, and establishes PRS-based risk stratification as a scalable, clinically impactful screening strategy.
Learn more
Download this cardiometabolic genomics/PRS presentation to understand how genetic risk insights can help guide prevention, lifestyle planning, and personalized long-term health management.
Learn more
Explore this presentation on coronary artery disease genomics/PRS to discover how genomic risk evaluation supports early identification, prevention planning, and smarter cardiovascular care.
Learn more
Access this educational presentation on breast cancer genomics/PRS to learn how advanced genetic risk assessment can inform early detection strategies and enable more personalized preventive care.
Learn more
Download this educational presentation on prostate cancer genomics/polygenic risk scoring (PRS) to learn how advanced genetic insights help assess individual risk, support earlier detection, and guide personalized, proactive care decisions.
Learn more
Discover how this innovative cardiovascular test evaluates risk for eight major heart conditions in one comprehensive assessment. The video highlights how early detection empowers smarter, preventive care for healthier outcomes.
Subscribe to get more video.
Avigena OmniInsight helps uncover genetic risk for prostate cancer, supporting earlier detection and more informed clinical decisions. Learn how precision genomics can guide proactive, personalized care.
Subscribe to get more video.
Avigena OmniInsight helps uncover genetic risk for prostate cancer, supporting earlier detection and more informed clinical decisions. Learn how precision genomics can guide proactive, personalized care.
Subscribe to get more video.
